Age-specific incidence rates of Alzheimer’s disease

Objective: To estimate age-specific incidence rates of AD in the Baltimore Longitudinal Study of Aging (BLSA). Background: The BLSA is a volunteer cohort of normal subjects followed longitudinally with biennial evaluations at the Gerontology Research Center of the National Institute on Aging. Methods: Subjects are 1236 participants (802 men, 434 women) in the BLSA with longitudinal follow-up between January 1985 and May 1998. The average length of follow-up was 7.5 years, with participants evaluated every 2 years by physical, neurologic, and neuropsychological examinations. Using Diagnostic and Statistical Manual of Mental Disorders, 3rd ed., revised and National Institute of Neurological and Communicative Disorders and Stroke–Alzheimer’s Disease and Related Disorders Association criteria, the authors diagnosed dementia and AD. Results: The authors diagnosed 155 cases of dementia, of which 114 (74%) were AD. Incidence rates of AD increased with age from an estimated 0.08% per year (95% CI 0.00 to 0.43) in the 60 to 65 age group to an estimated 6.48% per year (95% CI 5.01 to 8.38) in the 85+ age group for men and women combined. The doubling time of incidence rates was estimated to be approximately 4.4 years and the median time of conversion from mild cognitive impairment to diagnosis of AD was estimated to be 4.4 years. There was a trend for women to have higher incidence rates than men and for fewer years of education to be associated with higher incidence rates; however, these effects were not significant. Conclusion: Incidence rates for AD in the BLSA are consistent with published rates in other studies. The longitudinally followed subjects of the BLSA offer a unique opportunity to prospectively investigate the antecedents of AD.

[1]  A. Hofman,et al.  Rates and risk factors for dementia and Alzheimer’s disease , 1999, Neurology.

[2]  David Arenberg,et al.  Normal Human Aging: The Baltimore Longitudinal Study on Aging , 1984 .

[3]  Hyun Chul Lee,et al.  Low-Dose Growth Hormone Treatment with Diet Restriction Accelerates Body Fat Loss, Exerts Anabolic Effect and Improves Growth Hormone Secretory Dysfunction in Obese Adults , 1999, Hormone Research in Paediatrics.

[4]  Hiromitsu Iwamoto,et al.  Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population , 1995, Neurology.

[5]  C. M. van Duijn,et al.  Epidemiology of the dementias: recent developments and new approaches. , 1996 .

[6]  C. V. van Duijn,et al.  Epidemiology of the dementias: recent developments and new approaches. , 1996, Journal of neurology, neurosurgery, and psychiatry.

[7]  L. Radloff.  The CES-D Scale , 1977 .

[8]  B. Winblad,et al.  Very Old Women at Highest Risk of Dementia and Alzheimer's Disease , 1997, Neurology.

[9]  R Brookmeyer,et al.  Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. , 1998, American journal of public health.

[10]  T. Kurosaki,et al.  Measurement of functional activities in older adults in the community. , 1982, Journal of gerontology.

[11]  H. Buschke,et al.  Genuine memory deficits in dementia , 1987 .

[12]  M. Roth,et al.  The Association Between Quantitative Measures of Dementia and of Senile Change in the Cerebral Grey Matter of Elderly Subjects , 1968, British Journal of Psychiatry.

[13]  W. Jagust,et al.  Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers , 1992, Neurology.

[14]  N. Delanty,et al.  Risk of Alzheimer's disease and duration of NSAID use , 1998, Neurology.

[15]  R Brookmeyer,et al.  Reliability of the Blessed Telephone Information-Memory-Concentration Test , 1995, Journal of geriatric psychiatry and neurology.

[16]  N. Breslow,et al.  Statistical methods in cancer research. Volume II--The design and analysis of cohort studies. , 1987, IARC scientific publications.

[17]  Isabelle Rouleau,et al.  Quantitative and qualitative analyses of clock drawings in Alzheimer's and Huntington's disease , 1992, Brain and Cognition.

[18]  Arthur L. Benton,et al.  Differential behavioral effects in frontal lobe disease , 1968 .

[19]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[20]  A. Korten,et al.  The prevalence of dementia: A quantitative integration of the literature , 1987, Acta psychiatrica Scandinavica.

[21]  R. Brookmeyer,et al.  Sources of variability in prevalence rates of Alzheimer's disease. , 1995, International journal of epidemiology.

[22]  R. Katzman.,et al.  Pathological verification of ischemic score in differentiation of dementias , 1980, Annals of neurology.

[23]  A. Davies,et al.  The influence of age on trail making test performance. , 1968, Journal of clinical psychology.

[24]  D. Salmon,et al.  The prevalence of dementia and Alzheimer's disease in Shanghai, China: Impact of age, gender, and education , 1990, Annals of neurology.

[25]  E. Kaplan,et al.  The Boston naming test , 2001 .

[26]  R. Mayeux,et al.  Influence of education and occupation on the incidence of Alzheimer's disease. , 1994, JAMA.

[27]  B. Efron.  Logistic Regression, Survival Analysis, and the Kaplan-Meier Curve , 1988 .

[28]  D. Jolley,et al.  Cost benefits of a medically supervised day treatment program for patients with Alzheimer's disease and other forms of dementia , 1989 .

[29]  L A Beckett,et al.  Age-specific incidence of Alzheimer's disease in a community population. , 1995, JAMA.

[30]  R. Brookmeyer,et al.  A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease , 1997, Neurology.

[31]  H. Nelson,et al.  Dementia: The Estimation of Premorbid Intelligence Levels Using the New Adult Reading Test , 1978, Cortex.

[32]  J. Morris,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assesment of Alzheimer's disease , 1989, Neurology.

[33]  D Commenges,et al.  Incidence of dementia and Alzheimer's disease in elderly community residents of south-western France. , 1994, International journal of epidemiology.

[34]  R. Mohs,et al.  Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease. , 2002, Psychopharmacology bulletin.

[35]  R B D'Agostino,et al.  Incidence of dementia and probable Alzheimer's disease in a general population , 1993, Neurology.

[36]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[37]  I. Rossman,et al.  Normal Human Aging: The Baltimore Longitudinal Study of Aging , 1986 .

[38]  Reliability of the family history method in genetic studies of Alzheimer's disease and related dementias. , 1986, The American journal of psychiatry.

[39]  E. Kokmen,et al.  Trends in incidence of dementing illness in Rochester, Minnesota, in three quinquennial periods, 1960–1974 , 1988, Neurology.

[40]  F. Culasso,et al.  Prevalence of dementia in an elderly rural population: effects of age, sex, and education. , 1996, Journal of neurology, neurosurgery, and psychiatry.